Copy

Sponsored by   

 

Pharmalot Ed Silverman

As the 2020 campaign kicks off, Democrats scramble to prove their leadership on lowering drug costs

By Lev Facher

Scott Olson/Getty Images

A whole slate of 2020 Democratic hopefuls are suddenly fixating on the same policy target: high prescription drug prices.

Read More

STAT Plus: Digital health is attracting huge investments, but will patients buy it?

By Casey Ross

Justin Sullivan/Getty Images

Investment in digital health companies surged to $8.1 billion last year, a 25 percent increase from 2017 and a nearly eightfold increase from 2011.

Read More

STAT Plus: Sanofi-Genzyme inappropriately sought confidential patient information, suit alleges

By Kate Sheridan

DOMINICK REUTER/AFP/Getty Images

The lawsuit says the former employee made a formal, internal complaint about her manager's inappropriate request for confidential information.

Read More

Opinion: Virtual repurposing can speed the discovery of new uses for existing drugs

By Inga Peter

Adobe

Virtual repurposing uses big data and genomics to discover connections between seemingly "unconnected" diseases that may lead to new treatments.

Read More

STAT Plus: Up and down the ladder: The latest comings and goings

By Ed Silverman

Alex Hogan/STAT

Everyone wants to know who's on the move — and where.

Read More

Friday, January 11, 2019

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2019, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us
5cP.gif?contact_status=<<Contact Status>>